BRODY MARK S

SEC source: 0001248813-26-000005 · primarydocument.xml · derivative · entry 5

BRODY MARK S · CIK 0001248813 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 16,800

Underlying: Common Stock · 1,600 shares

Expires 2027-01-03

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · derivative.exercise_date: Vests 534 share(s) on 03-Jan-2018, 533 share(s) on 03-Jan-2019, 533 share(s) on 03-Jan-2020

SEC source: 0001248813-26-000005 · primarydocument.xml · nonDerivative · entry 2

BRODY MARK S · CIK 0001248813 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 113,854

F1 · price: This transaction was executed in multiple trades at prices ranging from $55.22 USD to $55.25 USD; the price reported above reflects the weighted average sale price.

F2 · balance_after: A total of 113,854 shares are beneficially owned by Dr. Mark Brody; 40,160 are held jointly with his spouse.

SEC source: 0001248813-26-000005 · primarydocument.xml · nonDerivative · entry 1

BRODY MARK S · CIK 0001248813 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 115,454

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001248813-26-000002 · primarydocument.xml · nonDerivative · entry 1

BRODY MARK S · CIK 0001248813 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,000

F1 · shares: 1,200 restricted shares were granted on 1/27/2026 from the 2023 Equity Compensation Plan and vest over four years; vesting commences with 300 shares on 1/27/2027, 300 shares on 1/27/2028, 300 shares on 1/27/2029, and 300 shares on 1/27/2030.

F2 · balance_after: 4,000 shares are held in an account at Computershare which have upcoming vesting dates.

SEC source: 0001562180-25-000819 · primarydocument.xml · derivative · entry 6

BRODY MARK S · CIK 0001248813 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 18,400

Underlying: Common Stock · 1,600 shares

Expires 2026-01-05

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: 18,400 stock options were granted under various dates and vesting periods of which all are currently exercisable.

F4 · balance_after: 18,400 stock options were granted under various dates and vesting periods of which all are currently exercisable.

SEC source: 0001562180-25-000819 · primarydocument.xml · nonDerivative · entry 2

BRODY MARK S · CIK 0001248813 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 71,802

F1 · balance_after: A total of 71,802 shares are beneficially owned by Dr. Mark Brody; 33,592 are held jointly with his spouse, 13,436 are held at Fidelity, 24,654 are held in an account at Shareworks, and 120 are held in an account at Computershare.

SEC source: 0001562180-25-000819 · primarydocument.xml · nonDerivative · entry 1

BRODY MARK S · CIK 0001248813 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 73,402

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001562180-25-000563 · primarydocument.xml · nonDerivative · entry 1

BRODY MARK S · CIK 0001248813 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,750

F1 · shares: 1,600 restricted shares were granted on 1/27/2025 from the 2023 Equity Compensation Plan and vest over four years; vesting commences with 400 shares on 1/27/2026, 400 shares on 1/27/2027, 400 shares on 1/27/2028, and 400 shares on 1/27/2029.

F2 · balance_after: 4,750 shares are held in an account at Computershare, which have upcoming vesting dates.

SEC source: 0001562180-24-007987 · primarydocument.xml · nonDerivative · entry 2

BRODY MARK S · CIK 0001248813 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 70,002

F1 · balance_after: A total of 70,002 shares are beneficially owned by Dr. Mark Brody; 33,592 are held jointly with his spouse, 13,436 are held at Fidelity, 22,854 are held in an account at Shareworks, and 120 are held in an account at Computershare.

SEC source: 0001562180-24-007987 · primarydocument.xml · nonDerivative · entry 1

BRODY MARK S · CIK 0001248813 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 72,802

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001562180-24-000174 · primarydocument.xml · nonDerivative · entry 1

BRODY MARK S · CIK 0001248813 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,950

F1 · shares: 2,200 restricted shares were granted on 1/2/2024 from the 2023 Equity Compensation Plan and vest over four years; vesting commences with 550 shares on 1/2/2025, 550 shares on 1/2/2026, 550 shares on 1/2/2027, and 550 shares on 1/2/2028.

F2 · balance_after: 4,950 shares are held in an account at Computershare, which have upcoming vesting dates.

SEC source: 0001562180-23-000203 · primarydocument.xml · nonDerivative · entry 1

BRODY MARK S · CIK 0001248813 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,000

F1 · shares: 2,000 restricted shares were granted on 1/3/2023 from the 2019 Equity Compensation Plan and vest over four years; vesting commences with 500 shares on 1/3/2024, 500 shares on 1/3/2025, 500 shares on 1/3/2026, and 500 shares on 1/3/2027.

F2 · balance_after: 4,000 shares are held in an account at Computershare, which have upcoming vesting dates.

SEC source: 0001562180-22-000264 · primarydocument.xml · nonDerivative · entry 1

BRODY MARK S · CIK 0001248813 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,975

F1 · shares: 2,000 restricted shares were granted on 1/3/2022 from the 2019 Equity Compensation Plan and vest over four years; vesting commences with 500 shares on 1/3/2023, 500 shares on 1/3/2024, 500 shares on 1/3/2025, and 500 shares on 1/3/2026.

F2 · balance_after: 2,975 shares are held in an account at Computershare, which have upcoming vesting dates.

SEC source: 0001562180-21-007568 · primarydocument.xml · nonDerivative · entry 1

BRODY MARK S · CIK 0001248813 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 67,077

F1 · price: This transaction was executed in multiple trades at prices ranging from $26.00 USD to $26.22 USD, the price reported above reflects the weighted average sale price.

F2 · balance_after: A total of 67,077 shares are beneficially owned by Dr. Brody; 33,712 are held in accounts at Computershare, of which 33,592 are held jointly with his spouse, 13,436 are held in street name, and 19,929 are held in an account at Shareworks.

SEC source: 0001562180-21-007537 · primarydocument.xml · nonDerivative · entry 1

BRODY MARK S · CIK 0001248813 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 69,267

F1 · price: This transaction was executed in multiple trades at prices ranging from $25.50 USD to $25.94 USD, the price reported above reflects the weighted average sale price.

F2 · balance_after: A total of 69,267 shares are beneficially owned by Dr. Brody; 33,712 are held in accounts at Computershare, of which 33,592 are held jointly with his spouse, 15,626 are held in street name, and 19,929 are held in an account at Shareworks.

SEC source: 0001562180-21-007293 · primarydocument.xml · nonDerivative · entry 1

BRODY MARK S · CIK 0001248813 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 70,069

F1 · price: This transaction was executed in multiple trades at prices ranging from $26.78 USD to $27.34 USD, the price reported above reflects the weighted average sale price.

F2 · balance_after: A total of 70,069 shares are beneficially owned by Dr. Brody; 33,712 are held in accounts at Computershare, of which 33,592 are held jointly with his spouse. 16,428 are held in street name, and 19,929 are held in an account at Shareworks.

SEC source: 0001562180-21-007241 · primarydocument.xml · nonDerivative · entry 2

BRODY MARK S · CIK 0001248813 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 71,144

F2 · price: This transaction was executed in multiple trades at prices ranging from $26.78 USD to $26.885 USD, the price reported above reflects the weighted average sale price.

F3 · balance_after: A total of 71,144 shares are beneficially owned by Dr. Brody; 33,592 are held jointly with his spouse, 17,503 are held in street name, 19,929 are held in an account at Shareworks, and 120 are held in an account at Computershare.

SEC source: 0001562180-21-007241 · primarydocument.xml · nonDerivative · entry 1

BRODY MARK S · CIK 0001248813 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 72,251

F1 · price: This transaction was executed in multiple trades at prices ranging from $27.07 USD to $27.25 USD, the price reported above reflects the weighted average sale price.

SEC source: 0001562180-21-006636 · primarydocument.xml · nonDerivative · entry 1

BRODY MARK S · CIK 0001248813 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 72,607

F1 · balance_after: A total of 72,607 shares are beneficially owned by Dr. Brody; 33,592 are held jointly with his spouse, 18,966 are held in street name, 19,929 are held in an account at Shareworks, and 120 are held in an account at Computershare.

SEC source: 0001562180-21-002919 · primarydocument.xml · nonDerivative · entry 1

BRODY MARK S · CIK 0001248813 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 73,617

F1 · balance_after: A total of 73,617 shares are beneficially owned by Dr. Brody; 39,558 are held jointly with his spouse,13,000 are held in street name, 20,939 are held in an account at Shareworks, and 120 are held in an account at Computershare.

SEC source: 0001562180-21-000223 · primarydocument.xml · derivative · entry 5

BRODY MARK S · CIK 0001248813 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 22,800

Underlying: Common Stock · 4,000 shares

Expires 2031-01-04

F5 · shares: 4,000 stock options were granted on 1/4/2021 from the 2019 Equity Compensation Plan.

F6 · derivative.exercise_date: 33+% per year for 3 years beginning on 1/4/2021.

F7 · balance_after: 22,800 stock options were granted under various dates and vesting periods of which 13,400 are currently exercisable.

SEC source: 0001562180-21-000223 · primarydocument.xml · nonDerivative · entry 1

BRODY MARK S · CIK 0001248813 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,675

F1 · shares: 1,000 restricted shares were granted on 1/4/2021 from the 2019 Equity Compensation Plan and vest over four years; vesting commences with 250 shares on 1/4/2022, 250 shares on 1/4/2023, 250 shares on 1/4/2024, and 250 shares on 1/4/2025.

F2 · balance_after: 1,675 restricted shares are held in an account at Computershare, which have upcoming vesting dates.

SEC source: 0001562180-20-004165 · primarydocument.xml · nonDerivative · entry 1

BRODY MARK S · CIK 0001248813 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 81,659

F1 · balance_after: A total of 81,659 shares are beneficially owned by Dr. Brody; 48,400 are held jointly with his spouse, 13,000 are held in street name, 20,139 are held in an account at Shareworks, and 120 are held in an account at Computershare.

SEC source: 0001562180-20-003103 · primarydocument.xml · nonDerivative · entry 2

BRODY MARK S · CIK 0001248813 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 82,674

F2 · shares: 295 shares were purchased in Mr. Brody's SEP-IRA account @ $11.74.

F3 · balance_after: A total of 82,674 shares are beneficially owned by Dr. Brody; 48,400 are held jointly with his spouse, 13,000 are held in street name, 21,154 are held in an account at Shareworks, and 120 are held in an account at Computershare.

SEC source: 0001562180-20-000181 · primarydocument.xml · derivative · entry 5

BRODY MARK S · CIK 0001248813 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,800

Underlying: Common Stock · 6,600 shares

Expires 2030-01-02

F4 · shares: 6,600 stock options were granted on 1/2/2020 from the 2019 Equity Compensation Plan.

F5 · derivative.exercise_date: 33+% per year for 3 years beginning on 02-Jan-2020

F6 · balance_after: 18,800 stock options were granted under various dates and vesting periods of which 9,133 are currently exercisable.

SEC source: 0000920427-19-000040 · wf-form4_154663639148126.xml · nonDerivative · entry 1

BRODY MARK S · CIK 0001248813 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,155

F1 · shares: 900 restricted shares were granted on 1/2/19 from the 2013 Stock Bonus Plan and vest over four years; vesting commences with 225 shares on 1/2/20, 225 shares on 1/2/21, 225 shares on 1/2/22, and 225 shares on 1/2/23.

F2 · balance_after: 3,155 restricted shares are held in an account at Computershare, which have upcoming vesting dates.

SEC source: 0000920427-18-000145 · wf-form4_154584018921823.xml · derivative · entry 5

BRODY MARK S · CIK 0001248813 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,200

Underlying: Common Stock · 3,000 shares

Expires 2028-12-21

F4 · shares: 3,000 stock options were granted on 12/21/18 at $18.25 per share, which vest 1/3 per year; i.e., 1,000 on 12/21/19; 1,000 on 12/21/20; and 1,000 on 12/21/21.

F5 · balance_after: 12,200 stock options were granted under various dates and vesting periods of which 3,467 are currently exercisable.

SEC source: 0000920427-19-000013 · wf-form4a_154646127446606.xml · derivative · entry 1

BRODY MARK S · CIK 0001248813 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,200

Underlying: Common Stock · 3,000 shares

Expires 2028-12-21

F1 · price: Incorrectly filed as $18.25 - price of derivative security. Adjusted to $18.77, prior day closing market price.

SEC source: 0000920427-18-000116 · wf-form4_154394779947750.xml · derivative · entry 5

BRODY MARK S · CIK 0001248813 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,200

Underlying: Common Stock · 2,200 shares

Expires 2018-12-18

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · shares: Dr. Brody exercised 2,200 stock options at $3.46 per share, and sold at $22.40 per share.

F5 · balance_after: 9,200 stock options were granted of which 3,467 are currently exercisable.

SEC source: 0000920427-18-000089 · wf-form4_153254602749174.xml · derivative · entry 6

BRODY MARK S · CIK 0001248813 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,400

Underlying: Common Stock · 661 shares

Expires 2018-12-18

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · shares: Dr. Brody exercised 661 stock options at $3.46 per share, and sold at $25.35 per share.

F6 · balance_after: 11,400 stock options were granted of which 5,667 are currently exercisable.

SEC source: 0000920427-18-000089 · wf-form4_153254602749174.xml · derivative · entry 5

BRODY MARK S · CIK 0001248813 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,061

Underlying: Common Stock · 1,539 shares

Expires 2018-12-18

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · shares: Dr. Brody exercised 1,539 stock options at $3.46 per share, and sold at $25.24 per share.

SEC source: 0000920427-18-000077 · wf-form4a_152648438544607.xml · derivative · entry 1

BRODY MARK S · CIK 0001248813 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,600

Underlying: Common Stock · 2,200 shares

Expires 2018-12-18

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: Incorrectly filed as $2,200 - value of shares disposed. Adjusted to 2,200 shares disposed.

SEC source: 0000920427-18-000073 · wf-form4_152647483090945.xml · derivative · entry 5

BRODY MARK S · CIK 0001248813 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,600

Underlying: Common Stock · 2,200 shares

Expires 2018-12-18

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · reported_value: Dr. Brody exercised 2,200 stock options at $3.46 per share, and sold at $23.00 per share.

F5 · balance_after: 13,600 stock options were granted of which 7,867 are currently exercisable.

SEC source: 0000920427-18-000055 · wf-form4_152114496999229.xml · derivative · entry 5

BRODY MARK S · CIK 0001248813 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,800

Underlying: Common Stock · 2,200 shares

Expires 2018-12-18

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · reported_value: Dr. Brody exercised 2,200 stock options at $3.46 per share, and sold at $22.50 per share.

F5 · balance_after: 15,800 stock options were granted of which 10,067 are currently exercisable.

SEC source: 0000920427-18-000075 · wf-form4a_152648423122467.xml · derivative · entry 1

BRODY MARK S · CIK 0001248813 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,800

Underlying: Common Stock · 2,200 shares

Expires 2018-12-18

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: Incorrectly filed as $2,200 - value of shares disposed. Adjusted to 2,200 shares disposed.

SEC source: 0000920427-18-000015 · wf-form4_151509010940827.xml · derivative · entry 5

BRODY MARK S · CIK 0001248813 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,000

Underlying: Common Stock · 3,200 shares

Expires 2028-01-02

F6 · shares: 3,200 stock options were granted on 1/2/18, which vest 1/3 per year; i.e., 1,067 on 1/2/19; 1,066 on 1/2/20; and 1,067 on 1/2/21.

F7 · balance_after: A total of 18,000 options were granted under various dates and vesting period of which 10,801 are currently exercisable.

SEC source: 0000920427-18-000015 · wf-form4_151509010940827.xml · nonDerivative · entry 1

BRODY MARK S · CIK 0001248813 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,930

F1 · shares: 900 restricted shares were granted on 1/2/18 from the 2013 Stock Bonus Plan and vest over four years; vesting commences with 225 shares on 1/2/19; 225 shares on 1/2/20; 225 shares on 1/2/21; and 225 shares on 1/2/22.

F2 · price: Stock price at the close of business on 12/29/17;

F3 · balance_after: 3,930 restricted stock shares are currently held in an account at Computershare, which have upcoming vesting dates.

SEC source: 0000920427-17-000081 · wf-form4_150524545300264.xml · derivative · entry 5

BRODY MARK S · CIK 0001248813 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,800

Underlying: Common Stock · 3,505 shares

Expires 2017-12-20

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · shares: Mr. Brody exercised 3,505 stock options at $6.46 per share, and sold at $17.50 per share.

F5 · derivative.exercise_date: 4,620 stock options were granted on 12/20/2007, which vested one-third per year commencing 12/20/2008; 12/20/2009; and 12/20/2010 at $6.46 per share that expire on 12/20/2017.

F5 · derivative.expiration_date: 4,620 stock options were granted on 12/20/2007, which vested one-third per year commencing 12/20/2008; 12/20/2009; and 12/20/2010 at $6.46 per share that expire on 12/20/2017.

F6 · balance_after: 14,800 stock options were granted to Mr. Brody of which 10,267 are currently exercisable.

SEC source: 0000920427-17-000075 · wf-form4_150464360163119.xml · derivative · entry 6

BRODY MARK S · CIK 0001248813 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,305

Underlying: Common Stock · 470 shares

Expires 2017-12-20

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · shares: Mr. Brody exercised 905 stock options at $6.46 per share, and sold at $17.50 per share.

F5 · derivative.exercise_date: 4,620 stock options were granted on 12/20/2007, which vested one-third per year commencing 12/20/2008; 12/20/2009; and 12/20/2010 at $6.46 per share that expire on 12/20/2017.

F5 · derivative.expiration_date: 4,620 stock options were granted on 12/20/2007, which vested one-third per year commencing 12/20/2008; 12/20/2009; and 12/20/2010 at $6.46 per share that expire on 12/20/2017.

F6 · balance_after: 18,305 stock options were granted to Mr. Brody of which 13,772 are currently exercisable.

SEC source: 0000920427-17-000075 · wf-form4_150464360163119.xml · derivative · entry 5

BRODY MARK S · CIK 0001248813 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,305

Underlying: Common Stock · 435 shares

Expires 2017-12-20

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · shares: Mr. Brody exercised 905 stock options at $6.46 per share, and sold at $17.50 per share.

F5 · derivative.exercise_date: 4,620 stock options were granted on 12/20/2007, which vested one-third per year commencing 12/20/2008; 12/20/2009; and 12/20/2010 at $6.46 per share that expire on 12/20/2017.

F5 · derivative.expiration_date: 4,620 stock options were granted on 12/20/2007, which vested one-third per year commencing 12/20/2008; 12/20/2009; and 12/20/2010 at $6.46 per share that expire on 12/20/2017.

F6 · balance_after: 18,305 stock options were granted to Mr. Brody of which 13,772 are currently exercisable.

SEC source: 0000920427-17-000073 · wf-form4_150429257671168.xml · derivative · entry 6

BRODY MARK S · CIK 0001248813 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,210

Underlying: Common Stock · 183 shares

Expires 2017-12-20

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · shares: Mr. Brody exercised 210 stock options at $6.46 per share, and sold at $17.50 per share.

F5 · derivative.exercise_date: 4,620 stock options were granted on 12/20/2007, which vested one-third per year commencing 12/20/2008; 12/20/2009; and 12/20/2010 at $6.46 per share that expire on 12/20/2017.

F5 · derivative.expiration_date: 4,620 stock options were granted on 12/20/2007, which vested one-third per year commencing 12/20/2008; 12/20/2009; and 12/20/2010 at $6.46 per share that expire on 12/20/2017.

F6 · balance_after: 19,210 stock options were granted to Mr. Brody of which 14,677 are currently exercisable.

SEC source: 0000920427-17-000073 · wf-form4_150429257671168.xml · derivative · entry 5

BRODY MARK S · CIK 0001248813 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,210

Underlying: Common Stock · 27 shares

Expires 2017-12-20

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · shares: Mr. Brody exercised 210 stock options at $6.46 per share, and sold at $17.50 per share.

F5 · derivative.exercise_date: 4,620 stock options were granted on 12/20/2007, which vested one-third per year commencing 12/20/2008; 12/20/2009; and 12/20/2010 at $6.46 per share that expire on 12/20/2017.

F5 · derivative.expiration_date: 4,620 stock options were granted on 12/20/2007, which vested one-third per year commencing 12/20/2008; 12/20/2009; and 12/20/2010 at $6.46 per share that expire on 12/20/2017.

F6 · balance_after: 19,210 stock options were granted to Mr. Brody of which 14,677 are currently exercisable.

SEC source: 0001248813-17-000001 · primary_doc.xml · derivative · entry 5

BRODY MARK S · CIK 0001248813 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,886

Underlying: Common Stock · 1,600 shares

Expires 2027-01-03

F3 · derivative.exercise_date: 1,600 stock options were granted on 1/3/17, which vest 1/3 per year; i.e., 534 on 1/3/18; 533 on 1/3/19; and 533 on 1/3/20.

F4 · balance_after: A total of 19,420 options were granted under various dates and vesting period of which 14,886 are currently exercisable.

SEC source: 0001248813-17-000001 · primary_doc.xml · nonDerivative · entry 1

BRODY MARK S · CIK 0001248813 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,800

F1 · shares: 1,400 restricted shares were granted on 1/3/17 from the 2013 Stock Bonus Plan and vest over four years; vesting commences with 350 shares on 1/3/18; 350 shares on 1/3/19; 350 shares on 1/3/20; and 350 shares on 1/3/21.

F2 · price: Stock price at the close of business on 12/30/16;

F7 · balance_after: 5,800 restricted stock shares are currently held in an account at Computershare, which have upcoming vesting dates.

SEC source: 0001248813-16-000001 · primary_doc.xml · derivative · entry 4

BRODY MARK S · CIK 0001248813 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,852

Underlying: Common Stock · 355 shares

Expires 2017-01-25

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: 3,032 stock options were granted on 1/25/2007, which were exercisable one-third commencing 1/25/2008; 1/25/2009 and 1/25/2010 and will expire on 1/25/2017. A "net-out" of the 3,032 stock options resulted in the issuance of 355 shares and the cancellation of 2,677 stock options.

F2 · derivative.underlying_shares: 3,032 stock options were granted on 1/25/2007, which were exercisable one-third commencing 1/25/2008; 1/25/2009 and 1/25/2010 and will expire on 1/25/2017. A "net-out" of the 3,032 stock options resulted in the issuance of 355 shares and the cancellation of 2,677 stock options.

F3 · balance_after: 20,852 stock options have been granted of which 16,452 are currently exercisable.

SEC source: 0001248813-16-000001 · primary_doc.xml · nonDerivative · entry 1

BRODY MARK S · CIK 0001248813 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 80,522

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · balance_after: 48,400 shares are held jointly with spouse.